Casirivimab-imdevimab neutralizing SARS-CoV-2: post-infusion clinical events and their risk factors

被引：0
|
作者：
Junichi Yoshida
Kenichiro Shiraishi
Tetsuro Tamura
Kazuhiro Otani
Tetsuya Kikuchi
Akiko Mataga
Takako Ueno
Masao Tanaka
机构：
[1] Infection Control Committee,Department of Medicine and Biosystemic Science
[2] Shimonoseki City Hospital,undefined
[3] Kyushu University Faculty of Medicine,undefined
来源：
Journal of Pharmaceutical Health Care and Sciences | / 8卷
关键词：
SARS-CoV-2; Casirivimab; Imdevimab; Fever; Hypoxia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] PRE-EXPOSURE PROPHYLAXIS FOR SARS-COV-2 INFECTION WITH SUBCUTANEOUS CASIRIVIMAB/IMDEVIMAB IN PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASES.
    Fagni, F.
    Schmidt, K.
    Bohr, D.
    Valor, L.
    Hartmann, F.
    Tascilar, K.
    Manger, K.
    Manger, B.
    Kleyer, A.
    Simon, D.
    Schett, G.
    Harrer, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 968 - 969
  • [22] Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection A Phase 2 Dose-Ranging Randomized Clinical Trial
    Portal-Celhay, Cynthia
    Forleo-Neto, Eduardo
    Eagan, Will
    Musser, Bret J.
    Davis, John D.
    Turner, Kenneth C.
    Norton, Thomas
    Hooper, Andrea T.
    Hamilton, Jennifer D.
    Pan, Cynthia
    Mahmood, Adnan
    Baum, Alina
    Kyratsous, Christos A.
    Kim, Yunji
    Parrino, Janie
    Kampman, Wendy
    Roque-Guerrero, Lilia
    Stoici, Roxana
    Fatakia, Adil
    Soo, Yuhwen
    Geba, Gregory P.
    Kowal, Bari
    DiCioccio, A. Thomas
    Stahl, Neil
    Lipsich, Leah
    Braunstein, Ned
    Herman, Gary A.
    Yancopoulos, George D.
    Weinreich, David M.
    JAMA NETWORK OPEN, 2022, 5 (08) : e2225411
  • [23] Casirivimab/imdevimab treatment for outpatient COVID-19 during a SARS-CoV-2 B1.617.2 (Delta) surge at a community hospital
    Keshishian, Erika
    Kuge, Elizabeth
    Memmott, Jordan
    Hasenbalg, Phillip
    Belford, Nakiya
    Matlock, Alexander
    Schritter, Sarah
    Agbayani, Geovar
    Dietrich, Tyson
    Santarelli, Anthony
    Ashurst, John
    JOURNAL OF OSTEOPATHIC MEDICINE, 2022, 122 (12): : 635 - 640
  • [24] Treatment with Sotrovimab and Casirivimab/Imdevimab Enhances Serum SARS-CoV-2 S Antibody Levels in Patients Infected with the SARS-CoV-2 Delta, Omicron BA.1, and BA.5 Variants
    Fujimoto, Kana
    Mutsuo, Satoru
    Yasuda, Yuto
    Arasawa, Soichi
    Tashima, Noriyuki
    Iwashima, Daisuke
    Takahashi, Ken-ichi
    INFECTIOUS DISEASE REPORTS, 2022, 14 (06) : 996 - 1003
  • [25] Evaluation of SARS-CoV-2 diagnostics and risk factors associated with SARS-CoV-2 infection in Zambia
    Tembo, John
    Egbe, Nkongho Franklyn
    Maluzi, Kwitaka
    Mulonga, Kangwa
    Chilufya, Moses
    Kapata, Nathan
    Mukonka, Victor
    Simulundu, Edgar
    Zumla, Alimuddin
    Fwoloshi, Sombo
    Mulenga, Lloyd
    Pallerla, Srinivas Reddy
    Velavan, Thirumalaisamy P.
    Bates, Matthew
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 120 : 150 - 157
  • [26] Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy
    Taha, Yusri
    Wardle, Hayley
    Evans, Adam B.
    Hunter, Ewan R.
    Marr, Helen
    Osborne, Wendy
    Bashton, Matthew
    Smith, Darren
    Burton-Fanning, Shirelle
    Schmid, Matthias L.
    Duncan, Christopher J. A.
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2021, 20 (01)
  • [27] Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy
    Yusri Taha
    Hayley Wardle
    Adam B. Evans
    Ewan R. Hunter
    Helen Marr
    Wendy Osborne
    Matthew Bashton
    Darren Smith
    Shirelle Burton-Fanning
    Matthias L. Schmid
    Christopher J. A. Duncan
    Annals of Clinical Microbiology and Antimicrobials, 20
  • [28] Review of the risk factors for SARS-CoV-2 transmission
    Xia Li
    Wei-Yi Xia
    Fang Jiang
    Dan-Yong Liu
    Shao-Qing Lei
    Zheng-Yuan Xia
    Qing-Ping Wu
    World Journal of Clinical Cases, 2021, 9 (07) : 1499 - 1512
  • [29] Review of the risk factors for SARS-CoV-2 transmission
    Li, Xia
    Xia, Wei-Yi
    Jiang, Fang
    Liu, Dan-Yong
    Lei, Shao-Qing
    Xia, Zheng-Yuan
    Wu, Qing-Ping
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (07) : 1499 - 1512
  • [30] Risk and protective factors of SARS-CoV-2 infection
    Takagi, Hisato
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (02) : 649 - 651
12345